{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:44:41Z","timestamp":1790549081585,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":410,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.modpat.2022.100084","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:47:50Z","timestamp":1673311670000},"page":"100084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Amir","family":"Momeni-Boroujeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridin","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kertowidjojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martee L.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ladanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Ellenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9698-0936","authenticated-orcid":false,"given":"Sarah","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2022.100084_bib1","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/1471-0528.14579","article-title":"Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome","volume":"124","author":"Cui","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.modpat.2022.100084_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JCO.2017.75.9845","article-title":"Soft tissue and uterine leiomyosarcoma","volume":"36","author":"George","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.modpat.2022.100084_bib3","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/cncr.27555","article-title":"Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions","volume":"118","author":"Mastrangelo","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2022.100084_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-018-0526-0","article-title":"Options for adjuvant therapy for uterine leiomyosarcoma","volume":"19","author":"Friedman","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.modpat.2022.100084_bib5","series-title":"Female genital tumours","first-page":"4","volume":"Volume 4","author":"Moch","year":"2020"},{"key":"10.1016\/j.modpat.2022.100084_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAS.0000000000001795","article-title":"Epithelioid leiomyosarcoma of the uterus: modern outcome-based appraisal of diagnostic criteria in a large institutional series","volume":"46","author":"Chapel","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/2008-132-595-SMTOTU","article-title":"Smooth muscle tumors of the uterus: a practical approach","volume":"132","author":"Toledo","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2022.100084_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/PAS.0b013e3182851162","article-title":"Interobserver variability in the interpretation of tumor cell necrosis in uterine leiomyosarcoma","volume":"37","author":"Lim","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1440-1827.2010.02549.x","article-title":"Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review","volume":"60","author":"Yanai","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.modpat.2022.100084_bib10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/modpathol.2009.96","article-title":"Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas","volume":"22","author":"Mittal","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2019.07.002","article-title":"Uterine smooth muscle tumors of unknown malignant potential: a challenging question","volume":"154","author":"Gadducci","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2022.100084_bib12","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia","volume":"29","author":"Oliva","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bpobgyn.2011.07.003","article-title":"Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential","volume":"25","author":"Ip","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.modpat.2022.100084_bib14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3390\/cancers12082126","article-title":"Genomic database analysis of uterine leiomyosarcoma mutational profile","volume":"12","author":"Astolfi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2022.100084_bib15","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.33542","article-title":"Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas","volume":"127","author":"Schaefer","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2022.100084_bib16","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-19-3959","article-title":"Genomic landscape of uterine sarcomas defined through prospective clinical sequencing","volume":"26","author":"Hensley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2022.100084_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PAS.0000000000000324","article-title":"Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome","volume":"39","author":"Liau","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Comm"},{"key":"10.1016\/j.modpat.2022.100084_bib19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","author":"Lazar","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.modpat.2022.100084_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7f5","article-title":"Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors","volume":"27","author":"Chen","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","article-title":"Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up","volume":"37","author":"Mills","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/his.13282","article-title":"Immunoexpression of p16 in uterine leiomyomas with infarct-type necrosis: an analysis of 35 cases","volume":"71","author":"Ip","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2022.100084_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","article-title":"Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential","volume":"50","author":"O'neill","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2022.100084_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00404-010-1690-z","article-title":"Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors","volume":"284","author":"\u00dcnver","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.modpat.2022.100084_bib25","first-page":"2795","article-title":"An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas","volume":"8","author":"Allen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/his.13124","article-title":"The mitosis-specific marker phosphohistone-H3 (PHH 3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study","volume":"70","author":"Chow","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2022.100084_bib27","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S0090-8258(21)00892-1","article-title":"Digital quantification of Ki-67 and PHH3 in the classification of uterine smooth muscle tumors","volume":"162","author":"Cao","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2022.100084_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cjp2.11","article-title":"Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma","volume":"1","author":"Slatter","year":"2015","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.modpat.2022.100084_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2022.100084_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.modpat.2022.100084_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.modpat.2022.100084_bib32","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.modpat.2022.100084_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-1114-x","article-title":"A\u00a0novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence","volume":"17","author":"Canisius","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.modpat.2022.100084_bib34","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/PO.20.00040","article-title":"CDKN2C-null leiomyosarcoma: a novel, genomically distinct class of TP53\/RB1\u2013wild-type tumor with frequent CIC genomic alterations and 1p\/19q-codeletion","volume":"4","author":"Williams","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2022.100084_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"M\u00e4kinen","year":"2016","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.modpat.2022.100084_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"Sherr","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2022.100084_bib37","first-page":"1","article-title":"Recent progress in mapping the emerging landscape of the small-cell lung cancer genome","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.modpat.2022.100084_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","article-title":"Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer","volume":"76","author":"Hamid","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.modpat.2022.100084_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejcsup.2019.12.001","article-title":"The hallmarks of ovarian cancer: proliferation and cell growth","volume":"15","author":"L\u00f3pez-Reig","year":"2020","journal-title":"Eur J Cancer Suppl"},{"key":"10.1016\/j.modpat.2022.100084_bib40","first-page":"1099","article-title":"Biology and pathogenesis of human osteosarcoma","volume":"19","author":"de Azevedo","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.modpat.2022.100084_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/his.14292","article-title":"p53 immunohistochemical analysis of fusion-positive uterine sarcomas","volume":"78","author":"Mohammad","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2022.100084_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.4442","article-title":"Targeted genomic analysis of M\u00fcllerian adenosarcoma","volume":"235","author":"Howitt","year":"2015","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/PAS.0000000000000907","article-title":"High-grade M\u00fcllerian adenosarcoma","volume":"41","author":"Hodgson","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41379-021-00855-1","article-title":"Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions","volume":"35","author":"Bennett","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41379-021-01004-4","article-title":"Melanocytic marker expression and TSC alterations\/TFE3 fusions in uterine PEComas","volume":"35","author":"Soslow","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib46","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with bizarre nuclei: a morphological, immunohistohemical and molecular analysis of 31 cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib47","first-page":"4554","article-title":"Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families","volume":"62","author":"Kiuru","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.modpat.2022.100084_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","article-title":"Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors","volume":"16","author":"Makinen","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.modpat.2022.100084_bib49","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","article-title":"Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors","volume":"29","author":"Liegl-Atzwanger","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib50","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/01.pas.0000170349.47680.e8","article-title":"Concordant loss of MTAP and p16\/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications","volume":"29","author":"Powell","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib51","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/his.13176","article-title":"Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour","volume":"70","author":"Schaefer","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2022.100084_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PGP.0000000000000688","article-title":"P16, Ki67, P53, and WT1 Expression in uterine smooth muscle tumors: an adjunct in confirming the diagnosis of malignancy in ambiguous cases","volume":"40","author":"Delgado","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PGP.0000000000000616","article-title":"Combination of MCM2 with Ki67 and p16 immunohistochemistry can distinguish uterine leiomyosarcomas","volume":"39","author":"Keyhanian","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.modpat.2022.100084_bib54","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/modpathol.2015.3","article-title":"Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions","volume":"28","author":"Croce","year":"2015","journal-title":"Mod Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222055247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222055247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:23:50Z","timestamp":1760232230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222055247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0893395222055247"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100084","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100084"}}